Charles Palmer

Charles Palmer

Auto-generated profile, based on publicly available information

Charles Palmer

Medical University of South Carolina, Department of Psychiatry and Behavioral Sciences (all authors), and Ralph H. Johnson VA Medical Center (George), Charleston

Research Focus & Metrics

Academic Career Length

4Years (2023-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
28 June 2025 in Movement Disorders Clinical Practice
Verified
Journal Article
Open access
CPCharles Palmer
Charles Palmer
AMAlexander McClanahan
Alexander McClanahan
FRFederico Rodriguez‐Porcel
Federico Rodriguez‐Porcel

1 January 2025 in International Journal of Hepatology
Verified
Journal Article
Open access
KCKelsey S. Coffman
Kelsey S. Coffman
GRGonzalo J. Revuelta
Gonzalo J. Revuelta
NDNathan DeTurk
Nathan DeTurk
CPCharles Palmer
Charles Palmer
HCHannah Culpepper
Hannah Culpepper
DTDavid J. Taber
David J. Taber
Background/Aims: Neurotoxicity is commonly seen in liver transplant (LT) patients receiving tacrolimus. We sought to determine the impact of LCP tacrolimus on neurologic toxicity in LT recipients. Methods: This single‐center, semiblinded, parallel group randomized controlled trial compared neurotoxicity burden in LT patients receiving immediate‐release (IR) tacrolimus versus LCP tacrolimus. Thirty LT recipients transplanted between January 2020 and February 2022 were enrolled between 15 and 364 days posttransplant and followed for 6 months postrandomization. The primary endpoint was change from baseline to 6 months in composite Patient Global Impression of Improvement (PGI‐I) score. Select secondary endpoints included change in Fahn–Tolosa–Marin (FTM) Tremor Rating Scale, IMAB‐Q10, SF‐12, and Medical Symptom Validity Test (MSVT) scores. Results: No significant differences were seen in composite PGI scores, though all patients saw improvement in overall PGI scores (IR −5 [−13.5 to −0.25] vs. LCP −4 [−9.5 to −0.5], p = 0.78). Other tests examining neurotoxicities showed no difference between groups but an overall trend toward improvement in symptoms between baseline and end of study. One episode of moderate rejection (rejection activity index [RAI] score of 6) was reported in the LCP group, with no episodes in the IR group ( p = 0.31). No graft loss or mortality occurred in either group. Conclusions: Our study showed LCP tacrolimus had similar rates of neurotoxicity in LT recipients compared to IR without increasing the risk of rejection, graft loss, or mortality; these results suggest LCP tacrolimus can be a safe alternative in LT recipients. Trial Registration: ClinicalTrials.gov identifier: NCT03823768

1 July 2025 in The Journal of Neuropsychiatry and Clinical Neurosciences
Verified
Journal Article
Closed access
CPCharles Palmer
Charles Palmer
NVNoah Vieira
Noah Vieira
ECElisabeth Collins
Elisabeth Collins
MDMorgan Dancy
Morgan Dancy
JCJoseph Chasen
Joseph Chasen
MGMark S. George
Mark S. George

1 December 2024 in Neurology Education
Verified
Journal Article
Open access
MRMattia Rosso
Mattia Rosso
TGTatiana Greige
Tatiana Greige
CPCharles Palmer
Charles Palmer
GPGreta Solinap Peng
Greta Solinap Peng
RARumyar V. Ardakani
Rumyar V. Ardakani
MSMichael P.H. Stanley
Michael P.H. Stanley
Perhaps stemming from the central role of detailed examinations and a focus on the subjective sphere that grounds their clinical practice, neurologists have frequently opined on experiences traditionally a province of humanities. The increasingly technological focus on medical education and care can be seen to devalue the subjective aspects of medicine. As a counter to this, we report on the existence of neurohumanities curricula within neurology residency training. We conducted an exploratory descriptive analysis of a convenience sample of 6 neurology residency programs in the United States with neurohumanities curricula. We reported the objectives of each program and feedback from participants. Finally, we described and identified patterns within the curricula and participant feedback. A shared feature of all programs was recency because all were started within the past decade. Seven sources of variability were timing, target audience, setting, scope of didactics, funding, regional differences, and objectives. The events ranged from mandatory to optional, from fully integrated in residency didactics to extracurricular. While residents were the primary audience across all programs, medical students and faculty were included as optional in some of the curricula. Objectives varied from clinical skill enhancement (e.g., improving observation through art), wellness (e.g., narrative medicine, self-reflection), to the scholarly exploration of the intersection between humanities and neuroscience. Our findings illustrated different ways of integrating humanities into neurology residency training. We highlighted the diverse approaches and objectives adopted by each program, which ranged from pedagogy to wellness. We hope this preliminary study will serve as a first step in the broader assessment of the needs, which neurohumanities curricula can address within neurology training. We also hope that this will lead to more formal assessment of the possible benefits of such implementation, which may include reflecting on clinical practice, debriefing from stressful events, and engaging with humanities.

2 August 2023 in Brain Stimulation
Verified
Journal Article
Closed access
CPCharles Palmer
Charles Palmer